Cascade-targeting multifunctional nanochaperone remodels brain microenvironment for synergistic therapy of Alzheimer’s disease
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Alzheimer's disease research and treatments · Neuroscience and Neuropharmacology Research · Endoplasmic Reticulum Stress and Disease
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. Alzheimer's disease10.1016/S0140-6736(20)32205-4 ↗
2. The Alzheimer disease market10.1038/nrd4749 ↗
3. Pathways towards and away from Alzheimer's disease10.1038/nature02621 ↗
4. Alzheimer mechanisms and therapeutic strategies10.1016/j.cell.2012.02.040 ↗
5. Lipoprotein-based nanoparticles rescue the memory loss of mice with Alzheimer's disease by accelerating the clearance of amyloid-beta10.1021/nn4058215 ↗
6. Development of multifunctional molecules as potential therapeutic candidates for Alzheimer's disease, Parkinson's disease, and Amyotrophic lateral sclerosis in the last decade10.1021/acs.chemrev.8b00138 ↗
7. Versatile nanomaterials for Alzheimer's disease: Pathogenesis inspired disease-modifying therapy10.1016/j.jconrel.2022.02.034 ↗
8. Biomimetic dendrimer-peptide conjugates for early multi-target therapy of Alzheimer's disease by inflammatory microenvironment modulation10.1002/adma.202100746 ↗
9. Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease10.1021/ja409801p ↗
10. The ongoing search for small molecules to study metal-associated amyloid-beta species in Alzheimer's disease10.1021/ar500152x ↗
11. The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization10.1021/cr3000994 ↗
12. Rapid formation of a preoligomeric peptide-metal-peptide complex following copper(II) binding to amyloid beta peptides10.1002/anie.201006335 ↗
13. Endo/lysosome-escapable delivery depot for improving BBB transcytosis and neuron targeted therapy of Alzheimer's disease10.1002/adfm.201909999 ↗
14. Overcoming the blood-brain barrier: the role of nanomaterials in treating neurological diseases10.1002/adma.201801362 ↗
15. Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer's disease therapy10.1126/sciadv.abc7031 ↗
16. Zhang, Nature-inspired dynamic gene-loaded nanoassemblies for the treatment of brain diseases
17. Strategies and materials of “SMART” non-viral vectors: overcoming thebarriers for brain gene therapy10.1016/j.nantod.2020.101006 ↗
18. The Hsp70 chaperone network10.1038/s41580-019-0133-3 ↗
19. Modulation of neurodegeneration by molecular chaperones10.1038/nrn1587 ↗
20. Bioinorganic chemistry of Alzheimer's disease10.1021/cr300009x ↗
21. Heat shock proteins as potential targets for protective strategies in neurodegeneration10.1016/S1474-4422(16)00099-5 ↗
22. The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-beta(1-40) peptide10.1038/nsmb.2191 ↗
23. Alpha(2)-macroglobulin and haptoglobin suppress amyloid formation by interacting with prefibrillar protein species10.1074/jbc.M807242200 ↗
24. Neuroserpin and transthyretin are extracellular chaperones that preferentially inhibit amyloid formation10.1126/sciadv.abf7606 ↗
25. Nanochaperone-based strategies to control protein aggregation linked to conformational diseases10.1002/anie.202007924 ↗
26. In vivo aspects of protein folding and quality control10.1126/science.aac4354 ↗
27. Chaperone machines for protein folding, unfolding and disaggregation10.1038/nrm3658 ↗
28. Maintenance of amyloid beta peptide homeostasis by artificial chaperones based on mixed-shell polymeric micelles10.1002/anie.201400735 ↗
29. Extracellular chaperones and proteostasis10.1146/annurev-biochem-072711-163904 ↗
30. Metal trafficking: from maintaining the metal homeostasis to future drug design10.1039/b904533c ↗
31. Induction of heat shock proteins for protection against oxidative stress10.1016/j.addr.2009.02.003 ↗
32. The biology of proteostasis in aging and disease10.1146/annurev-biochem-060614-033955 ↗
33. A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease10.1016/j.celrep.2014.09.042 ↗
34. A biocompatible second near-infrared nanozyme for spatiotemporal and non-invasive attenuation of amyloid deposition through scalp and skull10.1021/acsnano.0c02733 ↗
35. Targeting Alzheimer's disease with multimodal polypeptide-based nanoconjugates10.1126/sciadv.abf9180 ↗
36. Mimetic heat shock protein mediated immune process to enhance cancer immunotherapy10.1021/acs.nanolett.0c01230 ↗
37. Poly(beta-amino esters): synthesis, formulations, and their biomedical applications10.1002/adhm.201801359 ↗
38. A self-destructive nanosweeper that captures and clears amyloid beta-peptides10.1038/s41467-018-04255-z ↗
39. Nanoparticle cluster depolymerizes and removes amyloid fibrils for Alzheimer's disease treatment10.1016/j.nantod.2023.101756 ↗
40. Self-assembly molecular chaperone to concurrently inhibit the production and aggregation of amyloid beta peptide associated with Alzheimer's disease10.1021/acsmacrolett.8b00495 ↗
41. Tau-targeted multifunctional nanoinhibitor for Alzheimer's disease10.1021/acsami.1c00257 ↗
42. Femtosecond transient absorption spectroscopy of copper(II)-curcumin complexes10.1039/c2cp40208d ↗
43. Neuroprotective effects of curcumin10.1007/978-0-387-46401-5_8 ↗
44. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo10.1074/jbc.M404751200 ↗
45. Nanomaterials for reducing amyloid cytotoxicity10.1002/adma.201301210 ↗
46. Self-protecting biomimetic nanozyme for selective and synergistic clearance of peripheral amyloid-beta in an Alzheimer's disease model10.1021/jacs.0c08395 ↗
47. The synergistic effect between KLVFF and self-assembly chaperones on both disaggregation of beta-amyloid fibrils and reducing consequent toxicity10.1039/C6CC07803F ↗
48. Nanocomposites inhibit the formation, mitigate the neurotoxicity, and facilitate the removal of beta-amyloid aggregates in Alzheimer's disease mice10.1021/acs.nanolett.8b03644 ↗
49. Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization10.1021/bi700411k ↗
50. Lipoprotein-inspired nanoscavenger for the three-pronged modulation of microglia-derived neuroinflammation in Alzheimer's disease therapy10.1021/acs.nanolett.2c00191 ↗
51. An "amyloid-beta cleaner" for the treatment of Alzheimer's disease by normalizing microglial dysfunction10.1002/advs.201901555 ↗
52. Microenvironment remodeling micelles for Alzheimer's disease therapy by early modulation of activated microglia10.1002/advs.201801586 ↗
53. Engineering a pathological tau-targeted nanochaperone for selective and synergetic inhibition of tau pathology in Alzheimer's disease10.1016/j.nantod.2022.101388 ↗
54. Heat shock protein inspired nanochaperones restore amyloid-beta homeostasis for preventative therapy of Alzheimer's disease10.1002/advs.201901844 ↗